Determinants of therapeutic lag in relapsing multiple sclerosis

I Roos; F Frascoli; D Horakova; EK Havrdova; M Trojano; G Izquierdo; S Eichau; F Patti; A Prat; M Girard; P Duquette; M Onofr; A Lugaresi; P Grammond; S Ozakbas; P Sola; D Ferraro; R Bergamaschi; E Cartechini; MJ Sa; C Boz; F Grand'Maison; J Lechner-Scott; M Terzi; F Granella; R Alroughani; G Iuliano; R Hupperts; D Spitaleri; V Van Pesch; A Soysal; J Prevost; J Olascoaga; E Aguera-Morales; R Turkoglu; M Slee; C Ramo-Tello; Y Sidhom; R Gouider; P McCombe; H Butzkueven; C Malpas; T Kalincik

Journal article

Determinants of therapeutic lag in relapsing multiple sclerosis

I Roos, F Frascoli, D Horakova, EK Havrdova, M Trojano, G Izquierdo, S Eichau, F Patti, A Prat, M Girard, P Duquette, M Onofr, A Lugaresi, P Grammond, S Ozakbas, P Sola, D Ferraro, R Bergamaschi, E Cartechini, MJ Sa Show all

MULTIPLE SCLEROSIS JOURNAL | SAGE PUBLICATIONS LTD | Published : 2019

University of Melbourne Researchers

Izanne Roos Author

Charles Malpas Author

Tomas Kalincik Author

Related Projects (3)

PRECISION TREATMENT FOR MULTIPLE SCLEROSIS: MAXIMISING THE EFFECT OF IMMUNOMODULATORY THERAPY

Response to therapy varies greatly among patients with multiple sclerosis (MS). The current lack of individualised MS therapy may lead to su..

PRECISION THERAPY FOR NEUROLOGICAL DISEASES

Multiple sclerosis is the most common cause of neurological disability among young adults. The patients’ individual response to therapy is h..

BIOMARKERS TO PREVENT DISABILITY IN MULTIPLE SCLEROSIS

Response to therapy varies greatly among patients with multiple sclerosis (MS). The current lack of individualised MS therapy may lead to su..

Keywords

Neurosciences

Clinical Neurology

Life Sciences & Biomedicine

Neurosciences & Neurology

Science & Technology